Status:
UNKNOWN
Arterial Closure Device Comparison Trial II - ACDC Trial II
Lead Sponsor:
Unity Health Toronto
Conditions:
Arterial Hemostasis After Coronary Intervention
Eligibility:
All Genders
25+ years
Phase:
NA
Brief Summary
PCI (coronary angioplasty) is a procedure performed through a catheter to open up blockages in the coronary arteries using balloons and stents for the treatment of angina or myocardial infarction. The...
Detailed Description
All patients scheduled to undergo percutaneous coronary interventions will be screened for inclusion into the study. Informed consent will be obtained and patients will be randomized to the placement ...
Eligibility Criteria
Inclusion
- Patients undergoing non emergent PCI procedures with a 6F arterial sheath.
- Femoral artery anatomy favorable for the placement of an arterial closure device.
Exclusion
- Emergency PCI
- End stage renal disease
- Prior arterial closure device use within 90 days.
- Symptomatic peripheral vascular disease.
- Arterial puncture of the superficial femoral artery.
- Suspected double wall puncture (puncture of anterior \& posterior wall of femoral artery).
- Placement of intra aortic balloon pump.
- Placement of a femoral venous sheath.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
448 Patients enrolled
Trial Details
Trial ID
NCT00428155
Start Date
January 1 2007
Last Update
January 29 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Michael's Hospital
Toronto, Ontario, Canada, M5B1W8